A lower starting dose of 2mg partially mitigated the severity and frequency of nausea, vomiting, and diarrhea across all dose groups
Cost Considerations for Canadian Timeline Once approved, Retatrutide will likely follow similar pricing to other weight loss medications in Canada: Retail pricing: Expected $1,200-1,500 CAD monthly at maximum 12mg dose Provincial coverage: Varies by province
in: PubMed | Google Scholar | 1 Section of Integrative Physiology and Metabolism, Joslin Diabetes Center, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
It's a critical, non-negotiable element of the coverage puzzle